RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

Benzinga · 11/02 16:13
RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.